Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001241259 | SCV001414265 | benign | Nemaline myopathy 2 | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV002261319 | SCV002541866 | uncertain significance | not provided | 2021-07-08 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV002261319 | SCV003811493 | uncertain significance | not provided | 2019-07-08 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001241259 | SCV002084075 | uncertain significance | Nemaline myopathy 2 | 2020-01-17 | no assertion criteria provided | clinical testing |